Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


Rheumatoid Arthritis Drug Combined with Standard of Care May Help Reduce Mortality for Hospitalized COVID-19 Patients


 

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.

The study, led by principal investigators E. Wesley Ely, MD, MPH, Grant Liddle Professor of Medicine at Vanderbilt University Medical Center, and Vince Marconi, MD, of Emory University, included 1,525 hospitalized patients on supplemental oxygen from 101 centers across 12 countries in Asia, Europe, North America and South America.

Ely and Marconi received no financial compensation for their work on the study, which was funded by Eli Lilly and Company, the company that makes baricitinib, a medication known for its anti-inflammatory properties.

Patients in the COV-BARRIER trial were randomly assigned to receive baricitinib vs. placebo once a day for up to 14 days in addition to the standard of care, which included the medications dexamethasone and remdesivir.

The COV-BARRIER investigation discovered that baricitinib reduces 28-day and 60-day mortality by 5% as compared to placebo.

"Hospitalized patients with the SARS-CoV-2 infection (which causes COVID-19), often develop an intense hyperinflammatory state that can lead to dysfunction of multiple organs, including acute respiratory distress syndrome, septic shock and death," Ely said. "Despite treatment advances with remdesivir, dexamethasone and tocilizumab, reducing mortality among hospitalized patients remains a crucial unmet need.

"It is increasingly evident that treatment with baricitinib may help prevent death in some of the most critically ill COVID-19 patients, and that this class of medications represents an important treatment advance for this vulnerable group of patients in the constantly evolving pandemic," Ely said.

Baricitinib is an inhibitor of Janus kinases (JAK) 1 and 2, which "calms down your immune system," Ely said. "A huge computer analysis was done early in the pandemic, trying to figure out what drugs were the best to repurpose for COVID anti-viral effects," Ely said. "Anti-inflammatory effects are also important for sicker, hospitalized patients. JAK inhibitors selectively hit signaling via the JAK receptors, blocking transduction pathways that lead to inflammation," he said. "Drugs like baricitinib stop multiple pathways of the inflammatory cascade to hold down the inflammation that COVID would usually start."

Ely added that the COV-BARRIER data show that the sicker patients were at the time of enrollment, the greater the reduction in mortality.

Data from a COV-BARRIER addendum, which included hospitalized patients with COVID-19 on mechanical ventilation and ECMO (extracorporeal membrane oxygenation) at the time of enrollment, showed an even greater improvement in survival in the group given baricitinib, Ely said.

One surprising finding in the Lancet study is that although the drug reduces death, some patients still progress in their severity of illness.

"When COVID hits your body and the train is leaving the station, we did not find that this medication stopped the progress of the disease process entirely," Ely said. "If you were already sick, you continued to get a little sicker. The train keeps going a little bit, but adding baricitinib keeps you from going over the cliff into death."

Baricitinib was identified in February 2020 as a potential intervention for the treatment of COVID-19. The FDA granted Emergency Use Authorization (EUA) to the drug in November 2020, to be given in combination with the drug remdesivir, then amended the EUA later to allow baricitinib to be given with or without remdesivir.

Lilly is donating COVID-19 therapies to Direct Relief, enabling the humanitarian organization to provide COVID-19 therapies at no cost to low- and lower-middle-income countries most heavily impacted by the pandemic. In May, Lilly announced an initial donation of 400,000 baricitinib tablets to the Indian government for eligible hospitalized COVID-19 patients in India.

Share:

 

Email Print

 

More Grand Rounds:

 

Ascension Saint Thomas Rutherford to Invest in Facility Development

Ascension Saint Thomas Rutherford to Invest in Facility Development

Hospital Preparing for Higher Acuity Services

Read More

IVX Health Secures $100 Million Growth Investment from Great Hill Partners to Accelerate New Market Expansion

(BUSINESS WIRE)--IVX Health, a national provider of outpatient infusion centers, announced today the completion of a $100 million Series F minority investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies.

Read More

HCA Healthcare Agrees to Purchase Five Utah Hospitals from Steward Health Care

HCA Healthcare, Inc. (NYSE:HCA) and Steward Health Care announced the signing of a definitive agreement for HCA Healthcare to acquire the operations of Steward Health Care's five Utah hospitals.

Read More

KIMBERLY WELLS APPOINTED CEO OF PINEWOOD SPRINGS

KIMBERLY WELLS APPOINTED CEO OF PINEWOOD SPRINGS

Kimberly Wells has been appointed Chief Executive Officer (CEO) of Pinewood Springs in Columbia, Tenn., effective September 27, 2021. Wells currently serves as the Vice President of Operations for TriStar Horizon Medical Center in Dickson, Tenn.

Read More

NEW AHA ANALYSIS: TAX-EXEMPT HOSPITALS PROVIDED $105 BILLION IN TOTAL BENEFITS TO THEIR COMMUNITIES

Total Community Benefits Were 13.9% of Total Hospital Expenses in 2018

Read More

USAntibiotics Reopens Facility and Returns Antibiotic Production to the United States from China

USAntibiotics is the Only U.S. Manufacturer of Amoxicillin and Can Meet 100 Percent of the Nation's Demand

Read More

TRISTAR CENTENNIAL MEDICAL CENTER INTRODUCES TWO NEW VICE PRESIDENTS TO ITS SENIOR LEADERSHIP TEAM

TRISTAR CENTENNIAL MEDICAL CENTER INTRODUCES TWO NEW VICE PRESIDENTS TO ITS SENIOR LEADERSHIP TEAM

TriStar Centennial Medical Center is pleased to welcome Laura Godel as the hospital's new Vice President of Oncology Services, and Tyler Rhoden as its new Vice President of Orthopedics, Neurosciences, and Spine.

Read More

ZOOM NAMES MUSICIANS ON CALL SECOND PLACE OVERALL WINNER IN GLOBAL INNOVATION AWARDS

Nashville-based nonprofit honored in annual awards program for innovative use of the platform in delivering the healing power of music to hospitals during the pandemic

Read More

President Biden appoints Karen Winkfield to National Cancer Advisory Board

President Joe Biden has appointed Karen Winkfield, MD, PhD, to the National Cancer Advisory Board, where she will serve a six-year term and help guide federal initiatives that focus on cancer.

Read More

HCA HEALTHCARE NAMES SAMMIE MOSIER CHIEF NURSE EXECUTIVE; JANE ENGLEBRIGHT TO RETIRE AFTER NEARLY 30 YEARS OF SERVICE

HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, announced that Sammie Mosier will assume the role of senior vice president, chief nurse executive, effective December 1, 2021.

Read More

AHA RECEIVES $1 MILLION CDC GRANT TO CONTINUE VACCINE INITIATIVES

The American Hospital Association (AHA) announced today that the organization received $1 million in grant funding from the Centers for Disease Control and Prevention (CDC) to continue COVID-19 vaccine confidence efforts through September 2022.

Read More

Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals

Melt Expects to Dose First Patient in MELT-300 Phase 2 Study During September 2021

Read More

Franklin Dental Care to Host Free Dentistry Day Friday, October 1

Residents in the Franklin community and surrounding areas will have the opportunity to receive free dental services at Franklin Dental Care on Friday, October 1.

Read More

Family & Children's Service Awarded $8M to Support ACA Outreach and Enrollment

Family & Children's Service Awarded $8M to Support ACA Outreach and Enrollment

Nashville-Based Nonprofit Awarded Largest Federal Grant in its History

Read More

Edson James Andrews, Jr., M.D., F.A.C.R., F.A.C.C Obituary

Read More

Rheumatoid Arthritis Drug Combined with Standard of Care May Help Reduce Mortality for Hospitalized COVID-19 Patients

Rheumatoid Arthritis Drug Combined with Standard of Care May Help Reduce Mortality for Hospitalized COVID-19 Patients

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.

Read More

Help tackle the need by giving blood or platelets with the Red Cross

Help tackle the need by giving blood or platelets with the Red Cross

Red Cross and Sport Clips Haircuts partner to offer free haircut coupon to donors in September

Read More

SNAP benefit set to increase providing more dollars for low-income families to spend on food when pandemic relief expires

The Tennessee Justice Center applauds USDA for its reevaluation and cost adjustment of the Thrifty Food Plan, a measure that is used to calculate the monthly Supplemental Nutrition Assistance Program (SNAP) benefit allotment.

Read More

Gen Cap America Partners with Management to Acquire Lab Products

Gen Cap America, Inc. ("Gen Cap"), a private equity firm focused on lower middle market buyouts, announced that, in partnership with management, it has acquired Lab Products, LLC and Harford Systems, LLC (together, "Lab Products") from Avidity Science, LLC. Terms of the transaction were not disclosed.

Read More

New Podcast Provides Entertaining, Enlightening Glimpse into Lives of Area Seniors

New Podcast Provides Entertaining, Enlightening Glimpse into Lives of Area Seniors

In collaboration with Blakeford Senior Life, Ben Oddo is releasing a podcast series this Thursday, September 2, titled Me and All My Friends.

Read More

 
 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: